Dr. Biman Kumar Chakrabarty, SGCCRI

President, Founder President Retd. professor G & O Medical College, Kolkata
His key research interests are:i) embryological development of fallopian tube affecting ovarian cancer.ii)Rare gynecological tumours.iii )Multiple primary malignancies in gynecology.iv)gestational trophoblastic neoplasm.v)Adolescent ovarian epithelial carcinoma.vi)fertility preservation in gyne cancer.

Prof. Chitra Mandal, CSIR-IICB

Senior Scientist
Her key interest include sialoglycobiology of cancer and futuristic therapy using herbal molecules to meet unmet needs in ovarian/cervical cancer.

Dr. Asima Mukhopadhyay

Founder & Secretary and Director Consultant Gynaecological Oncology and Clinician Scientist
Her key research interest includes i) cytoreductive surgery ii)DDR and HRD in ovarian cancer iii) Health inequality and patient advocacy.

Dr. Rahul Roy Chowdhury, SGCCRI

Treasurer, Consultant Gynaecological Oncologist
His current research interest includes clinical trials and translational research in endometrial and ovarian cancer.

Dr. Chimay Kumar Panda

Joint Secretary, Scientist
Honorary Visiting Faculty Sr. Assistant Director Grade (Retd.) Head, Dept. of Oncogene Regulation Chittaranjan National Cancer Institute

Dr. Ranajit Kumar Mandal, CNCI

Joint Secretary, Treasurer Consultant Gynaecological Oncologist
His key research interest includes cervical cancer screening and HPV vaccination.

Dr. Santanu K Tripathi, MD, DM

Professor & Head Department of Clinical & Experimental Pharmacology
He leads the regulatory and ethics committee of several institutions in Kolkata including KolGOTrg.

Dr. Chanchal Goswami

Medical Oncologist and Chief Coordinator
He is a prominent member of several organisations such as Association of Radiation Oncologists of India (AROI),Indian Society of Oncology (ISO), American Society of ClinicalOncology,European Society of Medical Oncology & International Association of Study of Lung Cancer as well as KolGOTrg

Prof. Susanta Roychowdhury, SGCCRI

Vice President, Senior Scientist
His research group is working on the molecular understanding of the genomic instabilities, and functional consequences of gain-of function p53 mutations in human cancer. His group is also studying cancer cell plasticity in ovarian and endometrial cancer. Currently they are developing 3D organoid cell culture model and plasma cell free DNA based diagnostic assays in ovarian cancer.

Prof. Sharmila Sengupta

Her research group is working on to explore (i) the molecular epidemiology of CaCx in relation to HPV and (ii) host-pathogen interactions in HPV16 related CaCx cases, for understanding the natural history, susceptibility, and clinical progression.